Olema Pharmaceuticals, Inc. (OLMA)
25.58
-1.49
(-5.50%)
USD |
NASDAQ |
Jan 08, 16:00
25.77
+0.19
(+0.74%)
After-Hours: 19:44
Olema Pharmaceuticals Research and Development Expense (Annual): 124.52M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Cidara Therapeutics, Inc. | 71.88M |
| Cogent Biosciences, Inc. | 228.26M |
| Replimune Group, Inc. | 191.22M |
| Genprex, Inc. | 10.54M |